The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.25
Bid: 24.00
Ask: 24.50
Change: -1.00 (-3.96%)
Spread: 0.50 (2.083%)
Open: 25.25
High: 25.25
Low: 24.25
Prev. Close: 25.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Mitchells & Butlers Down Amid Raise Plan

Thu, 07th Jan 2021 10:51

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.

----------

FTSE 100 - WINNERS

----------

J Sainsbury, up 3.8%. The grocer's like-for-like sales in the nine weeks to January 2 - so including the key festive period - were up 9.3% year-on-year. For the whole of its third-quarter, like-for-like sales, excluding fuel, climbed 8.6%. Including fuel, like-for-like sales were up a more modest 3.2%.

----------

FTSE 100 - LOSERS

----------

Experian, down 2.4%. The stock went ex-dividend, meaning new buyers no longer qualify for the latest payout.

----------

FTSE 250 - LOSERS

----------

Trainline, down 7.8%. Launched an offering of GBP150 million of senior unsecured convertible bonds due 2026. The train booking platform operator in UK said the net proceeds of the five-year bonds will "provide additional liquidity, protecting the business further in an extended Covid downturn".

----------

Mitchells & Butlers, down 7.0%. Reports sharp 67% sales fall for 14 weeks to January 2 and adds that it is mulling an equity raise.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Sareum Holdings, up 10%. The Cambridge-based drug developer said the US Patent Office approved its patent application for an invention associated with its SDC-1802 TYK2/JAK1 kinase inhibitor programme

----------

James Fisher & Sons, up 7.9%. The marine services provider saw improved trading in its fourth quarter, so now expects 2020 underlying profit to be at the upper end of its guided range.

----------

Synectics, up 4.9%. The Sheffield, England-based provider of security systems has successfully deployed the first phase of its operational management system for German railway operator S-Bahn in Berlin.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Ormonde Mining, down 29%. Adjourns annual general meeting scheduled for Thursday. The Spain-focused natural resources firm says this is so it can continue talks with its largest shareholder over motions six to eight, concerning its share capital and ability to make market purchases.

----------

Joules Group, down 6.1%. The retailer said sales in the seven months trading period to January 3 were better than expected, though in-store sales in the seven weeks to January 3 plunged 58%.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Mar 2016 13:00

Sareum Holdings Unaware Of Reason For Share Price Jump

Read more
24 Feb 2016 12:25

Sareum inches closer to drug breakthrough

(ShareCast News) - Sareum Holdings was still running on the smell of an oily rag in its interim report on Wednesday, but the company was confident it was heading towards a breakthrough in its durgs under development. The AIM-traded cancer drug discovery and development business saw no revenue during

Read more
24 Feb 2016 09:40

Sareum Holdings Reports Narrowed Loss As It Focuses On CHK1 Trials

Read more
1 Feb 2016 09:14

Sareum Submits Clinical Trial Applications For Cancer Drug Candidate

Read more
15 Dec 2015 08:40

Sareum Clinical Trials Application For Cancer Drug Coming In January

Read more
8 Dec 2015 15:58

AGM, EGM Calendar - Week Ahead

Read more
26 Oct 2015 08:59

Sareum Holdings Loss Widens As It Moves Towards Clinical Trials

Read more
15 Sep 2015 08:06

Sareum Holdings Gets US, European Patents For Aurora+FLT3 Inhibitors

Read more
23 Jul 2015 09:06

Sareum Says Journal Reports On Lung And Pancreatic Cancer Treatment

Read more
17 Jun 2015 07:56

Sareum Wins Funding To Investigate Treatment Of Adolescent Leukaemia

Read more
28 May 2015 11:26

LONDON MIDDAY BRIEFING: Corporate Sponsors Join Backlash Against FIFA

Read more
28 May 2015 10:35

WINNERS & LOSERS: Sports Direct Expects Earnings To Beat Forecasts

Read more
28 May 2015 07:13

Sareum Raises GBP1.4 Million Via Discounted Share Placing (ALLISS)

Read more
12 May 2015 12:28

LONDON MIDDAY BRIEFING: EasyJet Outlook Hits Turbulence

Read more
12 May 2015 10:36

WINNERS & LOSERS: easyJet Slides As Analysts Set To Cut Forecasts

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.